It is still difficult for medical representatives in 2020, and Shanghai will issue rectification measures at the beginning of the year

[trends of pharmaceutical network industry] recently, the notice of Shanghai Municipal People's Government transmitting the implementation plan for correcting unhealthy practices in the field of pharmaceutical purchase and sale and medical services in 2019 issued by Shanghai Municipal Health Committee and other departments was clear, which will implement the registration and filing management in the pharmaceutical representative hospital, and crack down on the illegal tax related behaviors in the pharmaceutical industry At the same time, we will strengthen the inspection and handling of the issuance and use of invoices of pharmaceutical and consumable production and marketing units and medical institutions, strictly investigate illegal acts such as tax evasion, crack down on commercial bribery, money laundering and other illegal crimes, and maintain the order of the industry In fact, this is not the first time for Shanghai to issue rectification measures for medical representatives Previously, Shanghai Municipal Health and Health Commission issued "three rules and one rule" for the reception of medical representatives in the hospital: fixed time, fixed place, fixed personnel, and recorded regulations In fact, the frequent issuance of measures in Shanghai is due to the continuous introduction of relevant laws and regulations by the state in recent years to vigorously regulate the sales of pharmaceutical representatives This is mainly due to the fact that for a long time, some medical representatives have taken advantage of their identity to participate in drug sales such as product sales, drug unification, ticket payment processing, etc., or engaged in the behavior of disturbing the order of drug purchase and sale and medical service under the disguise of their identity as medical representatives, damaging the image of the industry and promoting the unhealthy trend Therefore, as early as December 2017, the State Food and Drug Administration and the state health and Family Planning Commission jointly issued the measures for the administration of registration and filing of medical representatives (Trial) (Draft for comments), which clarified the contents, qualifications, filing information and other matters of medical representatives According to the draft, medical representatives shall not undertake the task of drug sales, shall not participate in the statistics of drug prescriptions issued by doctors, and shall not directly sell physical drugs; medical institutions shall not allow personnel without record to carry out academic promotion and other related activities within the medical institutions, and medical personnel shall not participate in academic promotion and other activities without the approval of the medical institutions In July 2019, the notice on printing and distributing the key points of correcting the unhealthy trend in the field of medicine purchase and sale and medical services in 2019 jointly issued by 7 departments including the National Health Commission, the Ministry of industry and information technology, and the Ministry of Finance flowed out in some hospitals The general requirements are: improve the whole process supervision of pharmaceutical production and marketing, regulate the behavior of medical institutions and medical personnel, standardize the academic conferences in the medical field, maintain the high-pressure situation of cracking down on fraud and deception, and create a clean and healthy environment With the guidance of national policies, in addition to Shanghai, many provinces and hospitals have also introduced relevant measures For example, in October 2019, 10 departments of Guangxi autonomous region also jointly released the key points of Guangxi's work to correct the unhealthy trend in the field of pharmaceutical purchase and sale and medical services in 2019, requiring to improve the whole process supervision of pharmaceutical "purchase and sale", standardize the behavior of medical institutions and medical personnel, and academic conferences in the field of medical treatment On May 18, 2018, Tianjin Health and Family Planning Commission issued the Interim Measures for reception of representatives of internal pharmaceutical production and operation enterprises of Tianjin Medical and health institutions Among them, it is strictly prohibited for medical representatives to work in key areas of medical diagnosis and treatment (hereinafter referred to as "key areas of medical and health institutions") such as outpatient (emergency), inpatient department, laboratory, equipment department, material department, pharmacy and information management department It is strictly prohibited for medical representatives without prior record to enter the medical institution to carry out relevant business activities In fact, with the gradual implementation and promotion of belt purchase in pilot cities, the registration and filing of medical representatives in major provinces and cities and hospitals are becoming more and more popular, the space for sales with gold is being greatly reduced, and the anti-corruption red line of the pharmaceutical industry has been renewed again and again For example, the regulatory authorities in Shandong, Fujian, Hunan, Zhejiang and other provinces and cities have focused on the disclosure of registration and filing information of medical representatives in the annual government affairs publicity work Prior to this, many large hospitals in Shanghai, Beijing, Tianjin and other places have also started to implement the medical representative filing system This time, Shanghai announced the work plan for the whole year at the beginning of the year, indicating that the anti-corruption work of medicine is still the focus of rectification in 2020 There is no denying that a nationwide medical anti-corruption storm is also likely to grow.